ADSL and fungal infectious disease: The included AMPs have been the subject of preclinical or clinical studies against infections caused by Candida spp., or of preclinical or clinical studies for the treatment of fungal infections caused by other pathogens but that have been proven to have in vitro activity against Candida species (Table 1).